United States - COVID-19 Reported Patient Impact and Hospital Capacity by Facility 2020-2022 COVID-19 Reported Patient Impact and Hospital Capacity by Facility Epi surveillance: Health facility GHDx Entry last modified on: Aug 24, 2023
Italy Open Data on COVID-19 Vaccines 2020-2022 covid19-opendata-vaccini, Open Data su consegna e somministrazione dei vaccini anti COVID-19 in Italia Epi surveillance GHDx Entry last modified on: Aug 24, 2023
WHO Pulse Survey on Continuity of Essential Health Services During the COVID-19 Pandemic 2020-2021 - Round 2 Survey GHDx Entry last modified on: Aug 4, 2023
Covid-19 Vaccination Strategy In Spain 2020-2022 Estrategia De Vacunación Covid-19 En Espana Epi surveillance GHDx Entry last modified on: Aug 24, 2023
United States - COVID-19 Reported Patient Impact and Hospital Capacity by State Timeseries 2020-2022 Epi surveillance: Health facility - Subnationally representative GHDx Entry last modified on: Aug 24, 2023
Prevalence of SARS-CoV-2 antibodies in Denmark 2020: results from nationwide, population-based sero-epidemiological surveys. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
Seroprevalence of antibodies against SARS-CoV-2 virus in the adult Norwegian population, winter 2020/2021: pre-vaccination period. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
33.98% of Tripura has COVID-19 antibody in them, shows sero survey Survey: Epi surveillance GHDx Entry last modified on: May 12, 2022
Puerto Rico Community Assessment for Response to Public Health Emergencies (CASPER) 2020 Evaluación Comunitaria para la Respuesta a Emergencias de Salud Pública (CASPER) Survey: Epi surveillance GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Australia Household Impacts of Covid-19 Survey November 2020 Survey: Longitudinal GHDx Entry last modified on: Jan 25, 2023
Canada - British Columbia COVID-19 Situation Report 2020-2022 British Columbia (BC) COVID-19 Situation Report Epi surveillance GHDx Entry last modified on: Aug 24, 2023
High Seroprevalence of SARS-CoV-2 Eight Months After Introduction in Nairobi, Kenya. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
Serum-epidemiological Survey of SARS-CoV-2, Cities of Xai-Xai and Chókwè (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: Aug 2, 2022
South Africa COVID-19 Special Public Health Surveillance Bulletin, Volume 18 Supplementary Issue 9, 12 March 2021 COVID-19 Special Public Health Surveillance Bulletin Volume 18 (Issue 9: 12 Mar 2021) Epi surveillance: Cross-sectional - Individual GHDx Entry last modified on: Sep 9, 2022
India - Haryana Covid-19 Sero Survey Round 2, October 2020 Sero-prevalence of Anti-SARS-CoV-2 IgG antibodies in Haryana, India: A Population based Cross-Sectional Study (2nd Round) Survey: Cross-sectional - Epi surveillance - Urban-rural representative GHDx Entry last modified on: May 12, 2022
Brazil - Maranhão Prevalence of SARS-CoV-2 Virus Infection Survey 2020 Phase II Prevalência de infecção pelo vírus SARS-CoV-2 no Maranhão, segunda fase Survey: Individual - Interview GHDx Entry last modified on: Oct 21, 2022
Nepal National Sero-Prevalence Survey for COVID-19 2020 Round 1 ENHANCED SURVEILLANCE ON SERO-PREVALENCE OF SARS-COV-2 IN GENERAL POPULATION Survey GHDx Entry last modified on: May 12, 2022
Brazil - Sao Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, Phase 4 (SoroEpi MSP) Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 4 Survey GHDx Entry last modified on: Jun 26, 2023
Bhutan Royal Centre for Disease Control Quarterly Disease Surveillance Bulletin: Fourth Quarter, October-December 2020 RCDC Surveillance Bullletin, Volume 24, 4th Quarter 2020 (1st Quarter to 30 December) 2020 Epi surveillance: Subnationally representative GHDx Entry last modified on: Aug 6, 2021
4.7% of the Austrian population had antibodies against SARS-CoV -2 in mid / late October Epi surveillance GHDx Entry last modified on: May 12, 2022
Spain - Catalonia COVID-19 Weekly Confirmed Cases and Deaths 2020-2022 Incidència setmanal de la covid-19 Epi surveillance GHDx Entry last modified on: Aug 24, 2023
Seroprevalence in Tamil Nadu through India’s two COVID waves: Evidence on antibody decline following infection and vaccination. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
Canada COVID-19 Seroprevalence in Ontario: September 3 to October 30, 2020 Epi surveillance GHDx Entry last modified on: May 12, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Lichinga (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Lichinga (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: Aug 2, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Beira (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Beira (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: Aug 2, 2022
C''garh: 5.5 pc people have COVID-19 antibodies, says sero survey Survey: Cross-sectional - Epi surveillance - Individual GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 infections in kindergartens and associated households at the start of the second wave in Berlin, Germany – a cross sectional study. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Tete (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Tete (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: Aug 2, 2022
Andhra Pradesh Sero Survey Show Nearly 20% of State’s Population Exposed to Covid-19 Survey: Cross-sectional - Epi surveillance - Urban only GHDx Entry last modified on: May 12, 2022
Sweden - Uppsala First Wave COVID-19 ICU Patient Cohort Admitted Mar-Aug 2020, 3-6 Month Follow-up Sept-Nov 2020 Survey: Health facility - Individual - Interview - Longitudinal GHDx Entry last modified on: Apr 10, 2023
Population-based seroprevalence of SARS-CoV-2 antibodies in a high-altitude setting in Peru. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
20% of Andhra Exposed to Covid, Sero-survey Finds, Exposure Highest Where Case Tally Lowest Survey: Cross-sectional - Epi surveillance - Urban only GHDx Entry last modified on: Aug 1, 2022
India - Jharkhand Regional Outreach Bureau Twitter Communications and COVID-19 Updates 2020-2021 Epi surveillance GHDx Entry last modified on: Aug 25, 2023
Mexico - Yucatán Under-5 Endline Household Survey 2020 Survey: Cross-sectional - Household - Individual - Interview GHDx Entry last modified on: Mar 12, 2022
Seroprevalence of SARS-CoV-2 Infection Among Occupational Groups from Bucaramanga Metropolitan Area, Colombia. Preprint Scientific literature GHDx Entry last modified on: Oct 5, 2022
About 10 million people have been infected with the Corona virus in Afghanistan حدود ده ملیون تن در افغانستان به ویروس کرونا مبتلا شده اند Survey GHDx Entry last modified on: Jul 13, 2021
Serum-epidemiological Survey of SARS-CoV-2, City of Maputo (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Maputo (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: Aug 2, 2022
Canada COVID-19 Seroprevalence in Ontario: August 1 to August 31, 2020 COVID-19 Seroprevalence in Ontario: August 1 to August 31, 2020 Epi surveillance GHDx Entry last modified on: May 12, 2022
Sero-pravelence of SARS CoV-2 IgM and IgG Antibodies Amongst Blood Donors in Nigeria. Preprint Scientific literature: Epi surveillance GHDx Entry last modified on: Apr 8, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Quelimane (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Quelimane (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: Aug 2, 2022
Press Briefing: Sero Survey Delhi Survey: Cross-sectional - Urban only GHDx Entry last modified on: Feb 10, 2022
Over 56% of Delhi has Covid-19 Antibodies: Health Minister Satyendar Jain on 5th Serosurvey Survey: Urban only GHDx Entry last modified on: Apr 8, 2022
India - Haryana Covid -19 Sero Survey Round 1, August 2020 Sero-prevalence of anti-SARS-CoV-2 IgG antibodies in Haryana, India: a Population-Based Cross Sectional Study Survey: Epi surveillance GHDx Entry last modified on: May 12, 2022
29.1% people in Delhi developed antibodies against COVID-19, finds latest sero-survey Survey GHDx Entry last modified on: Aug 1, 2022
United States - Washington Hospitalized or Ambulatory Adults with Respiratory Viral Infections 2020 HAARVI Survey: Health facility - Longitudinal - Outpatient GHDx Entry last modified on: Apr 10, 2023
Assam's Sero-survey found 23.7 per cent Seroprevalence in the State Survey: Epi surveillance GHDx Entry last modified on: Aug 1, 2022
[Preliminary results of the National Health and Nutrition Survey COVID-19] Communiqué 255: Resultados preliminares de la Encuesta Nacional de Salud y Nutrición COVID-19 Survey: Cross-sectional - Epi surveillance - Household - Individual - Nationally representative GHDx Entry last modified on: May 12, 2022
Switzerland - Zurich COVID-19 Hospitalizations, Symptoms, Complications, Quality of Life, and Mental Wellbeing 2020-2021 Survey: Individual - Longitudinal GHDx Entry last modified on: Apr 10, 2023